加载中…
Cytokines and growth factors regulate growth, differentiation, and activation across lymphocytes, mast cells, endothelial cells, and beyond. This section covers interleukins, interferons, chemokines, the TNF superfamily, colony-stimulating factors, and growth factor families such as TGF-β, VEGF, EGF, and FGF—supporting immunology, cell biology, and drug discovery.
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
| Catalog # | Product / Synonym | Species | Expression | Protein structure |
|---|---|---|---|---|
| CD20-DB001 | Canine | Canine; HEK293; Recombinant Biotinylated Canine CD20/MS4A1 Nanodisc is expressed in HEK293 cells with a His tag at the C-terminus. It contains amino acid residues Met1-Pro297 (UniProt accession: Q3C2E2). | CD20/MS4A1 NanodiscHis N-terminusC-terminus AA segmentMet1-Pro297 | |
| CCL5-HP001 | Human | Human; E.coli; Recombinant Human CCL5 Protein is expressed in E. coli with a His-SUMO tag at the N-terminus. It contains amino acid residues Ser24-Ser91 (UniProt accession: P13501). | CCL5His N-terminusC-terminus AA segmentSer24-Ser91 | |
| BCMA-CF001 | Cynomolgus | Cynomolgus/Rhesus macaque; HEK293; Recombinant Cynomolgus/Rhesus macaque BCMA/TNFRSF17 Protein is expressed in HEK293 cells with an hFc (IgG1) at the C-terminus. It contains amino acid residues Met1-Ala53 (accession: A0A2K5UD97(Cynomolgus) / F7FFA0(Rhesus macaque)). | Cynomolgus/Rhesus macaque BCMA/TNFRSF17Fc N-terminusC-terminus AA segmentMet1-Ala53 | |
| SURVIVIN-HP001 | Human | Human; HEK293; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and LMLGEFLKL peptide | HLA-A*02:01&B2M&Survivin (LMLGEFLKL) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| NYESO1-HP006 | Human | Human; HEK293; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and SLLMWITQC peptide | HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| NYESO1-HP002 | Human | Human; HEK293; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and SLLMWITQC peptide | HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQC) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| NKG2D-HP001 | Human | Human; HEK293; Recombinant Human NKG2D/CD314 Protein is expressed in HEK293 cells with an Avi tag and His tag at the N-terminus. It contains amino acid residues Phe78-Val216 (UniProt accession: P26718). | Non-biotinylated Human NKG2D/CD314AviHis N-terminusC-terminus AA segmentPhe78-Val216 | |
| MRGPRX2-HP002 | Human | Recombinant Human MRGPRX2 Nanodisc is expressed from HEK293 with His tag at the C-terminus. It contains Met1-Val330 (accession: Q96LB1). | MRGPRX2 NanodiscHis N-terminusC-terminus AA segmentMet1-Val330 | |
| MRGPRX2-HP001 | Human | Recombinant Human MRGPRX2 VLP is expressed from HEK293. It contains Met1-Val330 (It may have cross reaction with anti-His antibody) (accession: Q96LB1). | MRGPRX2 VLPHis N-terminusC-terminus AA segmentMet1-Val330 | |
| MAGEA10-HB001 | Human | Human; HEK293; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and GLYDGMEHL peptide | HLA-A*02:01&B2M&MAGE-A10 (GLYDGMEHL) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASWT-HP005 | Human | Human; HEK293; Gly25-Thr305(HLA-A*03:01), Ile21-Met119(B2M) and VVVGAGGVGK peptide | HLA-A*03:01&B2M&KRAS WT (VVVGAGGVGK) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12V-HP010 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGAVGVGK peptide | HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12V-HP002 | Human | Human; HEK293; Gly25-Thr305(HLA-A*03:01), Ile21-Met119(B2M) and VVGAVGVGK peptide | HLA-A*03:01&B2M&KRAS G12V (VVGAVGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12S-HP001 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M)and VVVGASGVGK peptide | HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12D-HB004 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01),Ile21-Met119(B2M)and VVVGADGVGK peptide | HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| HPV16E7-HP005 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and IVCPICSQK peptide | HLA-A*11:01&B2M&HPV16 E7 (IVCPICSQK) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| HPV16E7-HB001 | Human | Human; HEK293; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and YMLDLQPET peptide | HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| HLAE0103-HP005 | Human | Human; HEK293; Gly22-Thr302(HLA-E*01:03) & Ile21-Met119(B2M) | Peptide Ready HLA-E*01:03&B2M MonomerAviHis N-terminusC-terminus AA segmentGly22-Thr302 | |
| HLAE0103-HB002 | Human | Human; HEK293; Gly22-Thr302(HLA-E*01:03), Ile21-Met119(B2M)and VMAPRTLVL peptide | HLA-E*01:03&B2M&Peptide (VMAPRTLVL) TetramerAviHis N-terminusC-terminus AA segmentGly22-Thr302 | |
| GPRC5D-HP002 | Human | Recombinant Human GPRC5D Nanodisc is expressed from HEK293 with His tag at the C-terminus. It contains Met1-Val345 (accession: Q9NZD1-1). | GPRC5D NanodiscHis N-terminusC-terminus AA segmentMet1-Val345 |
